CVS Health Corp. closed $34.74 short of its 52-week high ($80.75), which the company reached on March 28th.

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging margins.

In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on CVS Health (CVS – Research Report), with a price target of ...

Circadian Health has appointed Gregg Kimmer as its new chief executive officer (CEO) to enhance virtual-first speciality care ...

We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks ...

The Boston Globe Rhode Island's Christopher Gavin joined 12 News at 4 to discuss a federal lawsuit against CVS Health that ...